Maskos Michael相关文献与解析，生知库 | 链接生命科学的每一步

Molecular Insights into Function and Competitive Inhibition of Pseudomonas aeruginosa Multiple Virulence Factor Regulator

铜绿假单胞菌多重毒力因子调节剂的功能和竞争性抑制的分子见解

Tomoe Kitao, Francois Lepine, Seda Babloudi, Frederick Walte, Stefan Steinbacher, Klaus Maskos, Michael Blaesse, Michele Negri, Michael Pucci, Bob Zahler, Antonio Felici, Laurence G Rahme

信号转导

发表日期：2018

文献求助收藏

Protein corona - from molecular adsorption to physiological complexity

蛋白质冠——从分子吸附到生理复杂性

期刊:Beilstein Journal of Nanotechnology

影响因子:2.7

doi:10.3762/bjnano.6.88

Treuel, Lennart; Docter, Dominic; Maskos, Michael; Stauber, Roland H

发表日期：2015

文献求助收藏

In vitro investigation of silica nanoparticle uptake into human endothelial cells under physiological cyclic stretch.

在生理周期性拉伸条件下，对人内皮细胞吸收二氧化硅纳米颗粒的体外研究

期刊:Particle and Fibre Toxicology

影响因子:8.2

doi:10.1186/s12989-014-0068-y

Freese Christian, Schreiner Daniel, Anspach Laura, Bantz Christoph, Maskos Michael, Unger Ronald E, Kirkpatrick C James

Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems

尺寸会影响疏水性纳米颗粒对肺表面活性物质模型系统的作用。

期刊:Biophysical Journal

影响因子:3.1

doi:10.1016/j.bpj.2013.10.036

Dwivedi, Mridula V; Harishchandra, Rakesh Kumar; Koshkina, Olga; Maskos, Michael; Galla, Hans-Joachim

发表日期：2014

文献求助收藏

The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions

纳米颗粒的表面性质决定了其在生理条件下的团聚状态和尺寸。

期刊:Beilstein Journal of Nanotechnology

影响因子:2.7

doi:10.3762/bjnano.5.188

Bantz, Christoph; Koshkina, Olga; Lang, Thomas; Galla, Hans-Joachim; Kirkpatrick, C James; Stauber, Roland H; Maskos, Michael

发表日期：2014

文献求助收藏

The E. coli effector protein NleF is a caspase inhibitor

大肠杆菌效应蛋白 NleF 是一种 caspase 抑制剂

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0058937

Sonja Blasche, Mario Mörtl, Holger Steuber, Gabriella Siszler, Shahista Nisa, Frank Schwarz, Inna Lavrik, Thomas M A Gronewold, Klaus Maskos, Michael S Donnenberg, Dirk Ullmann, Peter Uetz, Manfred Kögl

免疫

发表日期：2013

文献求助收藏

Performance of nanoparticles for biomedical applications: The in vitro/in vivo discrepancy

纳米颗粒在生物医学应用中的性能：体外/体内差异

Molecular Insights into Function and Competitive Inhibition of Pseudomonas aeruginosa Multiple Virulence Factor Regulator

铜绿假单胞菌多重毒力因子调节剂的功能和竞争性抑制的分子见解

Protein corona - from molecular adsorption to physiological complexity

蛋白质冠——从分子吸附到生理复杂性

In vitro investigation of silica nanoparticle uptake into human endothelial cells under physiological cyclic stretch.

在生理周期性拉伸条件下，对人内皮细胞吸收二氧化硅纳米颗粒的体外研究

Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems

尺寸会影响疏水性纳米颗粒对肺表面活性物质模型系统的作用。

The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions

纳米颗粒的表面性质决定了其在生理条件下的团聚状态和尺寸。

The E. coli effector protein NleF is a caspase inhibitor

大肠杆菌效应蛋白 NleF 是一种 caspase 抑制剂